Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

ZYPADHERA 405 mg powder and solvent for prolonged release suspension for injection

Active Ingredient:
olanzapine pamoate monohydrate
Company:  
Neon Healthcare Ltd See contact details
ATC code: 
N05AH03
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Patient Alert Card

Zypadhera Patient Alert Card

{pdf_link}

Zypadhera Product Training

{healthcare_pro_orange} For Healthcare Professionals

Zypadhera Product Training

{pdf_link}

Zypadhera Reconstitution Training for Healthcare Professionals

{healthcare_pro_orange} For Healthcare Professionals

Zypadhera Reconstitution Training

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Neon Healthcare Ltd
Company image
Address
8 The Chase, John Tate Road, Foxholes Business Park, Hertford, Hertfordshire, SG13 7NN, UK
WWW
http://www.neonhealthcare.com
Telephone
+44 (0)1992 926 330
Medical Information Direct Line
+44 (0)1992 926 330
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)1992 926 330
Stock Availability
[email protected]
Stock Availability
+44 (0)1992 926 330